Document Detail


Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
MedLine Citation:
PMID:  18954493     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To evaluate hearing results following intratympanic gentamicin perfusion in patients with Ménière's disease. MATERIALS AND METHODS: Middle-ear perfusion of 0.4 ml of gentamicin 40 mg/ml solution was performed in Ménière's disease patients who had previously failed to respond to other medical treatment. RESULTS: Between May 1999 and November 2005, 22 patients (mean age 58.5 years) underwent intratympanic gentamicin perfusion. Mean follow up was 30 months. At the first post-perfusion visit (four to six weeks following perfusion), three of the 22 patients (13.63 per cent) had a pure tone average improvement of at least 10 dB, 15 (68.18 per cent) showed no change and four (18.18 per cent) demonstrated a decrease in hearing of more than 10 dB. Regarding speech discrimination scores, one patient (4.54 per cent) exhibited an improvement of at least 15 per cent, 15 (68.18 per cent) showed no change and six (27.27 per cent) showed a decrease of at least 15 per cent. After long-term follow up (12-40 months following perfusion), 10 patients (45.45 per cent) showed stable hearing, and 12 (54.54 per cent) exhibited a pure tone average decrease of more than 10 dB. Six patients (27.27 per cent) showed a speech discrimination score decrease of at least 15 per cent, while 16 (72.72 per cent) had no change. Complete cessation of vertigo was reported by 20 of the 22 patients (90.9 per cent), while two (9.09 per cent) reported episodic vertigo spells. CONCLUSION: Intratympanic gentamicin perfusion provides effective control of vertigo in patients with Ménière's disease. However, significant hearing loss may occur immediately after perfusion; therefore, this treatment should be considered only for patients whose hearing has already been affected by the disease.
Authors:
E Kyrodimos; I Aidonis; A Sismanis
Related Documents :
9601583 - Long-term functional sequelae after paediatric burns.
4047353 - Surgical decompression of anterior and posterior malignant epidural tumors compressing ...
20090293 - Amniopatch as a treatment for rupture of membranes following laser surgery for twin-twi...
Publication Detail:
Type:  Journal Article     Date:  2008-10-28
Journal Detail:
Title:  The Journal of laryngology and otology     Volume:  123     ISSN:  1748-5460     ISO Abbreviation:  J Laryngol Otol     Publication Date:  2009 Apr 
Date Detail:
Created Date:  2009-03-30     Completed Date:  2009-08-04     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8706896     Medline TA:  J Laryngol Otol     Country:  England    
Other Details:
Languages:  eng     Pagination:  379-82     Citation Subset:  AIM; IM    
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, Virginia Commonwealth University Medical Center, Richmond, Virginia 23298, USA. timkirodimos@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Aged, 80 and over
Anti-Bacterial Agents / administration & dosage*
Audiometry, Pure-Tone
Female
Gentamicins / administration & dosage*
Hearing Loss, Sensorineural / epidemiology*,  etiology
Humans
Incidence
Male
Meniere Disease / complications,  drug therapy*
Middle Aged
Retrospective Studies
Speech Perception / physiology
Tympanic Membrane
Vertigo / epidemiology,  etiology
Young Adult
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 0/Gentamicins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Introgression of a disrupted cadherin gene enables susceptible Helicoverpa armigera to obtain resist...
Next Document:  Auricular leishmaniasis mimicking squamous cell carcinoma.